Product

WCK 2349

1 clinical trial

1 indication

Indication

pharmacokinetics

Clinical trial

Phase-I Double-blind, Randomized, Placebo-controlled Single Center Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349 Under Fasting Conditions in Adult Healthy Human Volunteers

Status: Completed, Estimated PCD: 2011-05-04